COVID-19 Mass Vaccination

While the COVID-19 pandemic has adversely affected global economies and healthcare systems, mass vaccination presents a permanent way to transition out of it. However, accessibility of the vaccines and vaccine hesitancy provide significant challenges to mass vaccination programs. Nevertheless, the WHO-approved vaccines, including Pfizer, AstraZeneca, Janssen, and Moderna, have helped reduce the global infection curve, severe cases, and mortality associated with the disease. Consequently, governments and non-governmental organizations globally should raise awareness among the public about the benefits of taking COVID-19 vaccines. The vaccines should also be made widely available, particularly to the underdeveloped and developing nations, through the manufacturing of generic forms of COVID-19 vaccines that are relatively affordable.